Occurrence of AML in cells of donor origin after treatment of CML in relapse with imatinib and donor stem cell boost 16 years after the original allogeneic BMT. [electronic resource]
- Bone marrow transplantation Aug 2009
- 265-6 p. digital
Publication Type: Case Reports; Letter
1476-5365
10.1038/bmt.2009.8 doi
Aged Antineoplastic Agents--therapeutic use Benzamides Bone Marrow Transplantation Humans Imatinib Mesylate Leukemia, Myelogenous, Chronic, BCR-ABL Positive--pathology Leukemia, Myeloid, Acute--pathology Male Piperazines--therapeutic use Pyrimidines--therapeutic use